We found 527 records for "Regulatory / compliance"

Articles

Does real world evidence matter in Health Technology Assessments?

27th January 2015

 Does real world evidence matter in Health Technology Assessments?Articles

Health Technology Assessment (HTA) agencies usually rely on randomised controlled trials for clinical data when evaluating drugs, but these do not always tell the entire story. Both biopharmaceutical companies and...

Read more

Unleashing the power of data-driven medicine

23rd January 2015

 Unleashing the power of data-driven medicineArticles

Genomic data can now be analysed and used to diagnose conditions and tailor treatments to individual patients, but concerns over broader data sharing and security need to be overcome for...

Read more

Cancer Drugs Fund: winners and losers in pharma, but a long-term fix is needed

22nd January 2015

 Cancer Drugs Fund: winners and losers in pharma, but a long-term fix is neededArticles

Roche to pioneer 'multi-indication pricing' for Avastin – is this part of a future solution?Last week's decision to make cuts to England's Cancer Drugs Fund caused dismay among some patient...

Read more

Does the drug industry need a new pricing model?

12th January 2015

 Does the drug industry need a new pricing model?Articles

Various approaches have been taken to try to balance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term. Advances in drug development are...

Read more

News

Genzyme extends Gaucher disease options in Europe

26th January 2015

 Genzyme extends Gaucher disease options in EuropeNews

The European Commission (EC) has granted marketing authorisation for Genzyme's orphan drug Cerdelga (eliglustat), a first-line oral therapy for adults living with Gaucher disease type 1 (GD1).The drug was licensed...

Read more

Regeneron/Sanofi in pole position for PCSK inhibitor launch

26th January 2015

 Regeneron/Sanofi in pole position for PCSK inhibitor launchNews

Sanofi and Regeneron could have approval for their new cholesterol-lowering drug alirocumab in the US before the end of July, giving it a real chance of beating rival Amgen to...

Read more

Bayer’s Xarelto makes grade in NICE final draft guidance

23rd January 2015

 Bayer’s Xarelto makes grade in NICE final draft guidanceNews

In final draft guidance UK health watchdog NICE has confirmed its earlier positive draft decision recommending Bayer's Xarelto (rivaroxaban) as an option for preventing blood clots in people who have...

Read more

Novo Nordisk gets CHMP backing for obesity drug Saxenda

23rd January 2015

 Novo Nordisk gets CHMP backing for obesity drug SaxendaNews

Novo Nordisk has won a Committee for Medicinal Products for Human Use (CHMP) endorsement for a higher-dose version of its diabetes drug liraglutide that can be used to treat obesity.The...

Read more

White Papers

"The future ain’t what it used to be"

25th November 2014

 "The future ain’t what it used to be"White Papers

Preparation is key to creating and maintaining a strong drugs pipeline. However, the statistics demonstrate that successful product commercialisation strategies are not always implemented. Products are developed for which there...

Read more

Healthcare Innovation: the big ideas shaping the future of pharma

17th November 2014

 Healthcare Innovation: the big ideas shaping the future of pharmaWhite Papers

The transformation taking place in healthcare is challenging for everyone and adaptability is key for the pharma industry's continued success.Long production cycles, concentration on specialist drugs with high price tags,...

Read more

How pharma Tweetchats can drive healthcare innovation

29th April 2014

 How pharma Tweetchats can drive healthcare innovationWhite Papers

During the course of 2013 Boehringer Ingelheim explored the use of multi-way communication on Twitter, via Tweetchats, as a means to better understand disease area issues and directly connect with...

Read more

Who are the pharma social media butterflies?

19th March 2014

 Who are the pharma social media butterflies?White Papers

Social media has got everyone talking and it seems like everyone in pharma is talking about social media, so Ogilvy Healthworld figured it was time to analyse who were the...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Events

The European Medical Devices Regulation

27th January 2015 - 28th January 2015

The European Medical Devices Regulation

European Medical Device Regulations in September 2012, industry has been attempting to gain a firm idea of what needs to be done to ensure preparation and compliance. Informa Life Sciences’...

Read more

5th Annual Pharma R&D Asia Congress

27th January 2015 - 28th January 2015

5th Annual Pharma R&D Asia Congress

The 5th Annual Pharma R&D World Asia congress will discuss novel scientific innovations in Discovery and Development in Asia. Topics will cover: global collaboration, changes in the model of CRO...

Read more

7th annual Pre-Filled Syringes

28th January 2015 - 29th January 2015

7th annual Pre-Filled Syringes

Join Pre-Filled Syringes- 2015 and be part of a major networking opportunity providing intimate interaction with your peers, where you will hear case studies, presentations and round table discussions on...

Read more

The Digital Pharma Advances Conference – Digital Strategies Delivering Real Results

28th January 2015

The Digital Pharma Advances Conference – Digital Strategies Delivering Real Results

Join 23 leading pharmaceuticals including GSK, Pfizer, Novartis, Roche, Janssen, Lundbeck and Leo Pharma and discover how to demonstrably deliver value and returns by engaging healthcare professionals, patients and stakeholders...

Read more

Press Releases

OPEN Health introduces its market access division OPEN Access Consulting

8th December 2014

OPEN Health introduces its market access division OPEN Access Consulting

Marlow, 4 December 2014: OPEN Health announced the launch of its dedicated market access division, OPEN Access Consulting. OPEN Access Consulting brings together existing market access expertise from Succinct Medical Communications...

Read more

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

23rd September 2014

3 TIPS FOR PATIENT ENGAGEMENT; DEFINE, ACT THEN ACCELERATE

Forbes blogger Leonard Kish described “patient engagement as the blockbuster drug of the century” namely for its potential impact on improving patient outcomes. Two years on from his article, I asked;...

Read more

PMCPA selects The EarthWorks as communications partner and app developer for new code

28th July 2014

PMCPA selects The EarthWorks as communications partner and app developer for new code

The Prescription Medicines Code of Practice Authority (PMCPA) announced today that it will be working in partnership with The EarthWorks to create a communications programme, including an app to help...

Read more

New WMF article on global healthcare gaps published

29th May 2014

New WMF article on global healthcare gaps published

WMF recently published an article in Pharmaceutical Physician, which looks at the shocking gaps in healthcare that exist across the world and summarises how the organisation is helping to improve...

Read more